Yamamoto T, Sasaki G, Sato T, Katayama I, Nishioka K
Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, Japan.
J Dermatol. 1995 Sep;22(9):650-4. doi: 10.1111/j.1346-8138.1995.tb03892.x.
Two cases of mycosis fungoides (MF) in the tumor stage were treated with intra-lesional interferon-gamma (IFN-gamma) therapy. After systemic chemotherapy, intra-lesional recombinant interferon-gamma was applied to the residual tumors. Intra-lesional IFN-gamma was sufficiently effective in the treatment of MF tumors, especially small-sized ones. Reverse transcriptase polymerase chain reaction (RT-PCR) analysis of messenger RNA expression of cytokines commonly detected interleukin-6 (IL-6) and IFN-gamma in the tumor cells before intra-lesional IFN-gamma. However, in our study, tumor cells in these cases did not exhibit the definitive cytokine patterns of Th1 or Th2.
两例肿瘤期蕈样肉芽肿(MF)患者接受了病灶内γ干扰素(IFN-γ)治疗。全身化疗后,将病灶内重组γ干扰素应用于残留肿瘤。病灶内IFN-γ在治疗MF肿瘤尤其是小尺寸肿瘤方面疗效显著。在病灶内注射IFN-γ之前,通过逆转录聚合酶链反应(RT-PCR)分析肿瘤细胞中常见细胞因子的信使核糖核酸表达,通常可检测到白细胞介素-6(IL-6)和IFN-γ。然而,在我们的研究中,这些病例的肿瘤细胞并未表现出明确的Th1或Th2细胞因子模式。